Half-year Report - Part 2 of 3

abrdn PLC
06 August 2024
 

abrdn plc

Half Year Results 2024

Part 2 of 3

2. Statement of Directors' responsibilities

Each of the Directors, whose names and functions are listed on the abrdn plc website, www.abrdn.com, confirms to the best of his or her knowledge and belief that:

-    The condensed consolidated income statement, the condensed consolidated statement of comprehensive income, the condensed consolidated statement of financial position, the condensed consolidated statement of changes in equity and the condensed consolidated statement of cash flows and associated notes, have been prepared in accordance with IAS 34 Interim Financial Reporting as adopted for use in the UK.

 

-    The interim management report includes a fair review of the information required by:

-    DTR 4.2.7R of the FCA's Disclosure Guidance and Transparency Rules Sourcebook, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed consolidated financial information and a description of the principal risks and uncertainties for the remaining six months of the year.

-    DTR 4.2.8R of the FCA's Disclosure Guidance and Transparency Rules Sourcebook, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period; and any changes in the related party transactions described in the last annual report that could do so.

-    As per principle N of the UK Corporate Governance Code, the Half year results 2024 taken as a whole, present a fair, balanced and understandable assessment of the Company's position and prospects.

 

The Directors are responsible for the maintenance and integrity of the corporate and financial information included on the Company's website. Legislation in the UK governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Changes to Directors during the period

As announced on 27 February, Catherine Bradley retired from the Board at the conclusion of the AGM on 24 April. Stephen Bird stepped down from the Board on 24 May. The Company also announced the appointment of Jason Windsor as Interim Group CEO on 24 May following the commencement of a formal CEO search process.

By order of the Board

 



Sir Douglas Flint

Chairman

5 August 2024

Jason Windsor

Interim Chief Executive Officer

5 August 2024

 

 

3. Independent review report to abrdn plc

 

Conclusion     

We have been engaged by abrdn plc ('the Company' or 'the Group') to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2024 which comprises condensed consolidated income statement, condensed consolidated statement of comprehensive income, condensed consolidated statement of financial position, condensed consolidated statement of changes in equity, condensed consolidated statement of cash flows and the related explanatory notes.

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2024 is not prepared, in all material respects, in accordance with IAS 34 Interim Financial Reporting as adopted for use in the UK and the Disclosure Guidance and Transparency Rules ('the DTR') of the UK's Financial Conduct Authority ('the UK FCA')

Basis for conclusion

We conducted our review in accordance with International Standard on Review Engagements (UK) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity ('ISRE (UK) 2410') issued for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. We read the other information contained in the half-yearly financial report and consider whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusions relating to going concern

Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for conclusion section of this report, nothing has come to our attention that causes us to believe that the directors have inappropriately adopted the going concern basis of accounting, or that the directors have identified material uncertainties relating to going concern that have not been appropriately disclosed.

This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410. However, future events or conditions may cause the Group to cease to continue as a going concern, and the above conclusions are not a guarantee that the Group will continue in operation.

Directors' responsibilities 

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA.

The annual financial statements of the Group are prepared in accordance with UK-adopted international accounting standards.

The directors are responsible for preparing the condensed set of financial statements included in the half-yearly financial report in accordance with IAS 34 as adopted for use in the UK.

In preparing the condensed set of financial statements, the directors are responsible for assessing the Group's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or to cease operations, or have no realistic alternative but to do so.

Our responsibility 

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review. Our conclusion, including our conclusions relating to going concern, are based on procedures that are less extensive than audit procedures, as described in the Basis for conclusion section of this report.

The purpose of our review work and to whom we owe our responsibilities

This report is made solely to the Company in accordance with the terms of our engagement to assist the Company in meeting the requirements of the DTR of the UK FCA. Our review has been undertaken so that we might state to the Company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company for our review work, for this report, or for the conclusions we have reached. 

 

Richard Faulkner

for and on behalf of KPMG LLP

Chartered Accountants
Saltire Court
20 Castle Terrace
Edinburgh
EH1 2EG

5 August 2024

 

4. Financial information

Condensed consolidated income statement

For the six months ended 30 June 2024



6 months

6 months

Full Year



2024

2023

2023


Notes

£m

£m

£m

Revenue from contracts with customers

4.4(a)

697

763

1,474

Cost of sales

4.4(b)

(30)

(42)

(76)

Net operating revenue


667

721

1,398






Restructuring and corporate transaction expenses

4.6

(51)

(113)

(152)

Impairment of intangibles acquired in business combinations and through the purchase of customer contracts

4.6

(5)

 

(37)

(63)

Amortisation of intangibles acquired in business combinations and through the purchase of customer contracts

4.6

(59)

 

(65)

(126)

Staff costs and other employee-related costs

4.6

(263)

(275)

(529)

Other administrative expenses

4.6

(295)

(274)

(593)

Total administrative and other expenses


(673)

(764)

(1,463)






Net gains or losses on financial instruments and other income





Fair value movements and dividend income on significant listed investments

4.5

13

 

(144)

(114)

Other net gains or losses on financial instruments and other income

4.5

72

26

116

Total net gains or losses on financial instruments and other income


85

(118)

2

Finance costs


(12)

(12)

(25)

Profit on disposal of subsidiaries and other operations

4.2(b)

88

-

79

Profit on disposal of interests in joint ventures

4.2(b)

11

-

-

Reversal of impairment of interests in joint ventures

4.12

-

-

2

Share of profit or loss from associates and joint ventures

4.12

21

4

1

Profit/(loss) before tax


187

(169)

(6)

Tax (expense)/credit

4.7

(16)

24

18

Profit/(loss) for the period


171

(145)

12

Attributable to:





Equity shareholders of abrdn plc


165

(151)

1

Other equity holders


6

6

11

Non-controlling interests - ordinary shares


-

-

-



171

(145)

12

Earnings per share





Basic (pence per share)

4.8

9.2

(7.7)

0.1

Diluted (pence per share)

4.8

9.1

(7.7)

0.1

 

The Notes on pages 25 to 49 are an integral part of this condensed consolidated financial information.

 

Condensed consolidated statement of comprehensive income

For the six months ended 30 June 2024



6 months

6 months

Full Year



2024

2023

2023


Notes

£m

£m

£m

Profit/(loss) for the period


171

(145)

12

Items that will not be reclassified subsequently to profit or loss:





Remeasurement gains/(losses) on defined benefit pension plans

4.17

72

(81)

(139)

Share of other comprehensive income of associates and joint ventures

4.12

1

-

(4)

Total items that will not be reclassified subsequently to profit or loss


73

(81)

(143)

Items that may be reclassified subsequently to profit or loss:





Fair value gains/(losses) on cash flow hedges


9

(13)

(40)

Exchange differences on translating foreign operations


(7)

(42)

(35)

Share of other comprehensive income of associates and joint ventures

4.12

(50)

(18)

(27)

Items transferred to the condensed consolidated income statement





Fair value (gains)/losses on cash flow hedges


(9)

30

28

Realised foreign exchange (gains)

4.2

-

-

(1)

Equity holder tax effect of items that may be reclassified subsequently to profit or loss

4.7

-

 

(4)

3

Total items that may be reclassified subsequently to profit or loss


(57)

(47)

(72)

Other comprehensive income for the period


16

(128)

(215)

Total comprehensive income for the period


187

(273)

(203)

Attributable to:





Equity shareholders of abrdn plc


181

(279)

(214)

Other equity holders


6

6

11

Non-controlling interests - ordinary shares


-

-

-



187

(273)

(203)

 

The Notes on pages 25 to 49 are an integral part of this condensed consolidated financial information.

 

Condensed consolidated statement of financial position

As at 30 June 2024



30 Jun

30 Jun

31 Dec



2024

20231

2023


Notes

£m

£m

£m

Assets





Intangible assets

4.11

1,514

1,548

1,578

Pension and other post-retirement benefit assets

4.17

821

772

740

Investments in associates and joint ventures accounted for using the equity method

4.12

198

 

245

229

Property, plant and equipment

4.13

150

162

163

Deferred tax assets


202

220

215

Financial investments

4.19

1,919

2,080

2,047

Receivables and other financial assets


1,262

1,238

1,071

Current tax recoverable


7

11

10

Other assets

4.14

74

100

77

Assets held for sale

4.15

11

83

19

Cash and cash equivalents


1,397

1,407

1,196



7,555

7,866

7,345

Assets backing unit linked liabilities

4.19




Financial investments


655

873

669

Receivables and other unit linked assets


8

8

4

Cash and cash equivalents


15

13

13



678

894

686

Total assets


8,233

8,760

8,031

Liabilities





Third party interest in consolidated funds

4.19

206

212

187

Subordinated liabilities


604

588

599

Pension and other post-retirement benefit provisions

4.17

12

9

12

Deferred tax liabilities


120

145

129

Current tax liabilities


5

6

6

Derivative financial liabilities

4.19

4

2

9

Other financial liabilities1


1,393

1,461

1,241

Provisions

4.18

62

58

66

Other liabilities


4

10

4

Liabilities of operations held for sale

4.15

2

6

2



2,412

2,497

2,255

Unit linked liabilities

4.19




Investment contract liabilities


670

724

684

Third party interest in consolidated funds


-

165

-

Other unit linked liabilities


8

5

2



678

894

686

Total liabilities


3,090

3,391

2,941

Equity





Share capital

4.16(a)

257

274

257

Shares held by trusts

4.16(b)

(132)

(147)

(141)

Share premium reserve

4.16(a)

640

640

640

Retained earnings


4,509

4,547

4,449

Other reserves


(343)

(159)

(327)

Equity attributable to equity shareholders of abrdn plc


4,931

5,155

4,878

Other equity


207

207

207

Non-controlling interests - ordinary shares


5

7

5

Total equity


5,143

5,369

5,090

Total equity and liabilities


8,233

8,760

8,031

1.  The Group has made a presentational change to show Deferred income within Other financial liabilities.

The Notes on pages 25 to 49 are an integral part of this condensed consolidated financial information.

 

Condensed consolidated statement of changes in equity

For the six months ended 30 June 2024



Share capital

Shares held by trusts

Share premium reserve

Retained earnings

Other reserves

Total equity attributable
to equity

shareholders of abrdn plc

Other equity

Non-controlling interests - ordinary shares

Total equity


Notes

£m

£m

£m

£m

£m

£m

£m

£m

£m

1 January 2024


257

(141)

640

4,449

(327)

4,878

207

5

5,090

Profit for the period


-

-

-

165

-

165

6

-

171

Other comprehensive income for the period


-

-

-

23

(7)

16

-

-

16

Total comprehensive income for the period


-

-

-

188

(7)

181

6

-

187

Issue of share capital

4.16(a)

-

-

-

-

-

-

-

-

-

Dividends paid on ordinary shares

4.10

-

-

-

(130)

-

(130)

-

-

(130)

Interest paid on other equity


-

-

-

-

-

-

(6)

-

(6)

Reserves credit for employee share-based payments


-

-

-

-

15

15

-

-

15

Transfer to retained earnings for vested employee share-based payments


-

-

-

24

(24)

-

-

-

-

Shares acquired by employee trusts


-

(10)

-

-

-

(10)

-

-

(10)

Shares distributed by employee and other trusts and related dividend equivalents


-

19

-

(21)

-

(2)

-

-

(2)

Aggregate tax effect of items recognised directly in equity

4.7

-

-

-

(1)

-

(1)

-

-

(1)

30 June 2024


257

(132)

640

4,509

(343)

4,931

207

5

5,143

 

 



Share capital

Shares held by trusts

Share premium reserve

Retained earnings1

Other reserves

Total equity attributable
to equity

shareholders of abrdn plc1

Other equity

Non-controlling interests - ordinary shares

Total equity1


Notes

£m

£m

£m

£m

£m

£m

£m

£m

£m

31 December 2022


280

(149)

640

4,986

(129)

5,628

207

7

5,842

Effect of application of IFRS 9 on Investments in associates and joint ventures accounted for using the equity method1


 

 

 

-

 

 

 

-

 

 

 

-

51

-

51

 

 

 

-

 

 

 

-

51

1 January 2023


280

(149)

640

5,037

(129)

5,679

207

7

5,893

(Loss)/profit for the period


-

-

-

(151)

-

(151)

6

-

(145)

Other comprehensive income for the period


 

-

 

-

 

-

(99)

(29)

(128)

 

-

 

-

(128)

Total comprehensive income for the period


 

-

 

-

 

-

(250)

(29)

(279)

6

-

(273)

Issue of share capital

4.16(a)

-

-

-

-

-

-

-

-

-

Dividends paid on ordinary shares

4.10

 

-

 

-

 

-

(142)

-

(142)

 

-

 

-

(142)

Interest paid on other equity


-

-

-

-

-

-

(6)

-

(6)

Share buyback

4.16(a)

(6)

-

-

(98)

6

(98)

-

-

(98)

Reserves credit for employee share-based payments


 

-

 

-

 

-

 

-

13

13

 

-

 

-

13

Transfer to retained earnings for vested employee share-based payments


 

 

-

 

 

-

 

 

-

20

(20)

 

 

-

 

 

-

 

 

-

 

 

-

Shares acquired by employee trusts


-

(19)

 

-

 

-

 

-

(19)

 

-

 

-

(19)

Shares distributed by employee and other trusts and related dividend equivalents


 

 

-

21

 

 

-

(22)

 

 

-

(1)

 

 

-

 

 

-

(1)

Aggregate tax effect of items recognised directly in equity

4.7

 

-

-

 

-

2

 

-

2

 

-

 

-

2

30 June 2023


274

(147)

640

4,547

(159)

5,155

207

7

5,369

1.  The Group implemented IFRS 9 in 2019. However, as permitted under a temporary exemption granted to insurers in IFRS 4 Insurance Contracts, the Group's insurance joint venture, Heng An Standard Life Insurance Company Limited (HASL), applied IFRS 9 at 1 January 2023 following the implementation of the new insurance contracts standard, IFRS 17. In line with the approach adopted by the Group on its implementation of IFRS 9 on 1 January 2019, the comparatives have not been restated for HASL's adoption of IFRS 9. The impact of HASL adopting IFRS 9 is recognised in retained earnings at 1 January 2023.

 



Share capital

Shares held by trusts

Share premium reserve

Retained earnings1

Other reserves

Total equity attributable
to equity

shareholders of abrdn plc1

Other equity

Non-controlling interests - ordinary shares

Total equity1


Notes

£m

£m

£m

£m

£m

£m

£m

£m

£m

31 December 2022


280

(149)

640

4,986

(129)

5,628

207

7

5,842

Effect of application of IFRS 9 on Investments in associates and joint ventures accounted for using the equity method1


 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

51

 

 

 

-

 

 

 

51

 

 

 

-

 

 

 

-

 

 

 

51

1 January 2023


280

(149)

640

5,037

(129)

5,679

207

7

5,893

Profit for the year


-

-

-

1

-

1

11

-

12

Other comprehensive income for the year


 

-

 

-

 

-

 

(170)

 

(45)

 

(215)

 

-

 

-

 

(215)

Total comprehensive income for the year


 

-

 

-

 

-

 

(169)

 

(45)

 

(214)

 

11

 

-

 

(203)

Issue of share capital

4.16(a)

-

-

-

-

-

-

-

-

-

Dividends paid on ordinary shares

4.10

 

-

 

-

 

-

 

(279)

 

-

 

(279)

 

-

 

-

 

(279)

Interest paid on other equity


-

-

-

-

-

-

(11)

-

(11)

Share buyback

4.16(a)

(23)

-

-

(302)

23

(302)

-

-

(302)

Other movements in non-controlling interests in the year


 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(2)

 

(2)

Reserves credit for employee share-based payments


 

-

 

-

 

-

 

-

 

24

 

24

 

-

 

-

 

24

Transfer to retained earnings for vested employee share-based payments


 

 

-

 

 

-

 

 

-

 

 

31

 

 

(31)

 

 

-

 

 

-

 

 

-

 

 

-

Transfer between reserves on impairment of subsidiaries

4.16(c)

 

-

 

-

 

-

 

169

 

(169)

 

-

 

-

 

-

 

-

Shares acquired by employee trusts


 

-

 

(27)

 

-

 

-

 

-

 

(27)

 

-

 

-

 

(27)

Shares distributed by employee and other trusts and related dividend equivalents


 

 

-

 

 

35

 

 

-

 

 

(38)

 

 

-

 

 

(3)

 

 

-

 

 

-

 

 

(3)

31 December 2023


257

(141)

640

4,449

(327)

4,878

207

5

5,090

1.  The Group implemented IFRS 9 in 2019. However, as permitted under a temporary exemption granted to insurers in IFRS 4 Insurance Contracts, the Group's insurance joint venture, HASL, applied IFRS 9 at 1 January 2023 following the implementation of the new insurance contracts standard, IFRS 17. In line with the approach adopted by the Group on its implementation of IFRS 9 on 1 January 2019, the comparatives have not been restated for HASL's adoption of IFRS 9. The impact of HASL adopting IFRS 9 is recognised in retained earnings at 1 January 2023.

The Notes on pages 25 to 49 are an integral part of this condensed consolidated financial information.

 

Condensed consolidated statement of cash flows

For the six months ended 30 June 2024



6 months

6 months

Full Year



2024

2023

2023


Notes

£m

£m

£m

Cash flows from operating activities





Profit/(loss) before tax


187

(169)

(6)

Change in operating assets


(129)

(86)

157

Change in operating liabilities


147

181

(109)

Adjustment for non-cash movements in investment income


(5)

(1)

3

Other non-cash and non-operating items


(21)

175

210

Taxation paid1


(9)

(23)

(34)

Net cash flows from operating activities


170

77

221

Cash flows from investing activities





Purchase of property, plant and equipment


(7)

(9)

(18)

Proceeds from sale of property, plant and equipment


1

-

-

Acquisition of subsidiaries and unincorporated businesses net of cash acquired


-

-

(108)

Disposal of subsidiaries net of cash disposed of


44

-

139

Acquisition of investments in associates and joint ventures


-

(2)

(2)

Proceeds in relation to contingent consideration


2

2

21

Payments in relation to contingent consideration


(4)

(4)

(12)

Disposal of investments in associates and joint ventures


20

-

-

Purchase of financial investments


(49)

(291)

(445)

Proceeds from sale or redemption of financial investments


197

871

1,029

Taxation paid on sale or redemption of financial investments1


-

(41)

(41)

Prepayment in respect of potential acquisition of customer contracts

4.21(b)

1

13

20

Acquisition of intangible assets


(3)

(35)

(41)

Net cash flows from investing activities


202

504

542

Cash flows from financing activities





Payment of lease liabilities - principal


(12)

(13)

(24)

Payment of lease liabilities - interest


(3)

(3)

(6)

Shares acquired by trusts


(9)

(19)

(27)

Interest paid on subordinated liabilities and other equity


(15)

(16)

(20)

Other interest paid


(1)

(2)

(3)

Cash received relating to collateral held in respect of derivatives hedging subordinated liabilities


8

 

(11)

(50)

Share buyback


-

(98)

(302)

Ordinary dividends paid

4.10

(130)

(142)

(279)

Net cash flows from financing activities


(162)

(304)

(711)

Net increase in cash and cash equivalents


210

277

52

Cash and cash equivalents at the beginning of the period


1,210

1,166

1,166

Effects of exchange rate changes on cash and cash equivalents


(5)

(16)

(8)

Cash and cash equivalents at the end of the period2


1,415

1,427

1,210

Supplemental disclosures on cash flows from operating activities





Interest received


42

37

85

Dividends received


40

53

91

Rental income received on investment property


2

2

3

1.  Total taxation paid for the six months ended 30 June 2024 was £9m (six months ended 30 June 2023: £64m, 12 months ended 31 December 2023: £75m).

2.  Comprises cash and cash equivalents, including cash and cash equivalents backing unit linked liabilities, and overdrafts which are reported in other financial liabilities in the condensed consolidated statement of financial position. Cash and cash equivalents at 30 June 2024 were £1,415m (30 June 2023: £1,427m, 31 December 2023: £1,210m) of which £3m (30 June 2023: £7m, 31 December 2023: £1m) is included in assets of operations held for sale in the condensed consolidated statement of financial position (refer Note 4.15). The Group had no overdrafts at 30 June 2024 (30 June 2023: £nil, 31 December 2023: £nil).

The Notes on pages 25 to 49 are an integral part of this condensed consolidated financial information.

 

Notes to the condensed consolidated financial statements

4.1   Presentation of the condensed consolidated financial statements

(a)      Basis of preparation

The condensed consolidated half year financial information has been prepared in accordance with IAS 34 Interim Financial Reporting as adopted for use in the UK and the Disclosure Guidance and Transparency Rules of the UK's Financial Conduct Authority.

The accounting policies for recognition, measurement, consolidation and presentation as set out in the Annual report and accounts for the year ended 31 December 2023 have been applied in the preparation of the condensed consolidated half year financial information except as noted below.

(a)(i)   New standards, interpretations and amendments to existing standards that have been adopted by the Group

The Group has adopted the following new International Financial Reporting Standards (IFRSs), interpretations and amendments to existing standards, which are effective for annual periods beginning on or after 1 January 2024.

Amendments to existing standards

-    Classification of Liabilities as Current or Non-current and Non-current Liabilities with Covenants - Amendments to IAS 1.

-    Lease Liability in a Sale and Leaseback - Amendments to IFRS 16.

-    Disclosures: Supplier Finance Arrangements - Amendments to IAS 7 and IFRS 7.

The Group's accounting policies have been updated to reflect these amendments. Management considers the implementation of the above amendments to have no significant impact on the Group's financial statements.

(b)      Going concern                    

The Group's business activities, together with the factors likely to affect its future development, performance and financial position, are set out in the Management report and in the Annual report and accounts 2023 Strategic report. This includes details on our liquidity and capital positions and our principal risks, including the impacts of the macroeconomic environment and global and regional geopolitical events on these principal risks.

In preparing these half year results on a going concern basis, the Directors have considered the following matters and have taken into account market uncertainty.

-    The Group has cash and liquid resources of £1.8bn at 30 June 2024. In addition, the Company has a revolving credit facility of £400m as part of our contingency funding plans which is due to mature in 2026 and remains undrawn.

-    The Group's indicative regulatory Common Equity Tier 1 (CET1) capital surplus on an IFPR basis was £954m in excess of capital requirements at 30 June 2024. The regulatory CET1 capital surplus does not include the value of the Group's significant listed investment in Phoenix Group Holdings (Phoenix).

-    The Group performs regular stress and scenario analysis as described in the Annual report and accounts 2023 Viability statement. The diverse range of management actions available meant the Group was able to withstand these extreme stresses.

-    The Group's operational resilience processes have operated effectively during the period including the provision of services by key outsource providers.

Based on a review of the above factors the Directors are satisfied that the Group and Company have and will maintain sufficient resources to enable them to continue operating for at least 12 months from the date of approval of the condensed consolidated financial statements. Accordingly, the financial statements have been prepared on a going concern basis. There were no material uncertainties relating to this going concern conclusion.

(c)      Condensed consolidated half year financial information

This condensed consolidated half year financial information does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Additionally, the comparative figures for the financial year ended 31 December 2023 are not the Company's statutory accounts for that financial year. The statutory accounts have been reported on by the Company's auditor and delivered to the Registrar of Companies. The report of the auditor was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006. The condensed consolidated half year financial information has been reviewed, not audited.

4.2   Acquisitions and disposals

(a)      Acquisitions

(a)(i) Prior period acquisitions of subsidiaries and other operations

Healthcare fund management capabilities of Tekla Capital Management

On 27 October 2023, abrdn Inc. purchased the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla) through a purchase agreement. Tekla's investment team transferred to the Group as part of the agreement. The assets under management at the acquisition date were £2.3bn. At acquisition the cash consideration was £108m and the fair value of deferred and contingent consideration was £11m. The acquisition further strengthens abrdn's closed-end fund business and allows the Group to draw on Tekla's expertise in investing in the healthcare sector as it looks to build out its offering in this area.

(b)      Disposals

(b)(i) Current period disposal of subsidiaries and other operations

European-headquartered Private Equity business

Profit on disposal of subsidiaries and other for the six months ended 30 June 2024 relates to the sale of the Group's European-headquartered Private Equity business to Patria Investments. The sale completed on 26 April 2024. The European-headquartered Private Equity business was reported in the Investments segment.

 

The gain on sale before tax, which is included in profit on disposals of subsidiaries and other operations in the condensed consolidated income statement for the six months ended 30 June 2024 for the European-headquartered Private Equity business was calculated as follows:

26 April 2024

£m

Total assets of operations disposed of

(29)

Total liabilities of operations disposed of

11

Net assets of operations disposed of

(18)

Cash consideration (less transaction costs) and outstanding intercompany balances1,2

70

Fair value of deferred/contingent consideration and retained interest3

36

Gain on sale before tax

88

1.  Following the completion of the sale, £3m relating to a number of unsettled outstanding intercompany balances which previously eliminated on consolidation are now recognised as an asset of the Group.

2.  Included in cash consideration is £10m for additional upfront consideration which is determined based on the net assets of the European-headquartered Private Equity business following a number of adjustments detailed in the sale price agreement. The additional consideration of £10m is a provisional figure and remains subject to agreement with Patria Investments.

3.  The Group has also retained certain carried interest entitlements which has been recognised in the condensed consolidated statement of financial position at a fair value of £6m.

Prior to the completion of the sale, the European-headquartered Private Equity business was classified as an operation held for sale (refer Note 4.15).

(b)(ii)              Current period disposal of joint ventures

Virgin Money Unit Trust Managers (Virgin Money UTM)

Profit on disposal of interests in joint ventures for the six months ended 30 June 2024 of £11m relates to the sale of the Group's interest in Virgin Money UTM to its joint venture partner, Clydesdale Bank, on 2 April 2024 for a cash consideration of £20m. Prior to the sale, the Group's interest in Virgin Money UTM was classified as held for sale and had a carrying value of £9m (refer Note 4.15). The interest in Virgin Money UTM did not form part of the Group's reportable segments.

(b)(iii) Prior period disposal of subsidiaries and other operations

There were no disposals of subsidiaries and other operations during the six months ended 30 June 2023.

During the 12 months ended 31 December 2023, the Group made two material disposals of subsidiaries and other operations:

-    On 1 September 2023, the Group completed the sale of abrdn Capital Limited (aCL), its discretionary fund management business, to LGT UK Holdings Limited.

-    On 2 October 2023, the Group completed the sale of its US Private Equity and Venture Capital capabilities to HighVista Strategies LLC.

aCL and the Group's US Private Equity and Venture Capital capabilities were reported in the ii (previously named Personal) and Investments segments respectively.

Other disposals included the sale of abrdn Australia Ltd to Melbourne Securities Corporation Limited on 1 July 2023. The disposal is not considered material to the Group.

Profit on disposal of subsidiaries and other operations for the 12 months ended 31 December 2023 have been summarised below.


£m

Disposal of aCL

58

Disposal of US Private Equity and Venture Capital capabilities

22

Other disposals

(1)

Profit on disposal of subsidiaries and other operations for the 12 months ended 31 December 2023

79

On disposal, a net gain of £1m was recycled from the translation reserve and was included in determining the profit on disposal of subsidiaries and other operations for the 12 months ended 31 December 2023.

4.3   Segmental analysis

The Group's reportable segments have been identified in accordance with the way in which the Group is structured and managed. IFRS 8 Operating Segments requires that the information presented in the financial statements is based on information provided to the 'Chief Operating Decision Maker' which for the Group is the executive leadership team.

(a)      Basis of segmentation

(a)(i)   Current reportable segments

Investments

Our global asset management business which provides investment solutions for Institutional, Retail Wealth and Insurance Partners clients.

Adviser

Our UK financial adviser business which provides platform services to wealth managers and advisers.

interactive investor (ii) (previously named Personal)

ii, our direct investing platform, and our financial planning business, abrdn Financial Planning and Advice. It also included the Group's discretionary fund management business until the completion of the sale of aCL on 1 September 2023. Refer Note 4.2(b)(iii) for further details.

In addition to the Group's reportable segments above, the analysis of adjusted profit in Section 4.3(b)(i) below also reports the following:

Other business operations and corporate costs (Other)

Other comprises of Finimize and our digital innovation group along with certain corporate costs.

(a)(ii)              Changes to basis of segmentation

As noted above, the Group reports Other in addition to its reportable segments. For the six months ended 30 June 2023, the Group had previously only reported certain corporate costs in addition to its reportable segments (reported as Corporate/strategic). These costs are now reported within Other along with Finimize and our digital innovation group which were previously reported within Investments. Including Finimize and our digital innovation group within Other rather than the Investments reportable segment is considered to provide a clearer depiction of business structure and performance. Comparative amounts for the six months ended 30 June 2023 have now been prepared on a consistent basis. Comparative amounts for the 12 months ended 31 December 2023 were already prepared on this basis.

(b)      Reportable segments - adjusted profit and revenue information

(b)(i) Analysis of adjusted profit

Adjusted operating profit is presented by reportable segment in the table below.



Investments

Adviser

ii

Other

Total

6 months 2024

Notes

£m

£m

£m

£m

£m

Net operating revenue

4.4

406

119

137

5

667

Adjusted operating expenses


(372)

(54)

(82)

(31)

(539)

Adjusted operating profit


34

65

55

(26)

128

Adjusted net financing costs and investment return






42

Adjusted profit before tax






170

Tax on adjusted profit






(41)

Adjusted profit after tax






129

Adjusted for the following items







Restructuring and corporate transaction expenses

4.6





(51)

Amortisation and impairment of intangible assets acquired in business combinations and through the purchase of customer contracts

4.6





(64)

Change in fair value of significant listed investments

4.5





(15)

Profit on disposal of subsidiaries and other operations






88

Profit on disposal of interests in joint ventures






11

Dividends from significant listed investments

4.5





28

Share of profit or loss from associates and joint ventures






21

Other

4.9





(1)

Total adjusting items including results of associates and joint ventures






17

Tax on adjusting items






25

Profit attributable to other equity holders






(6)

Profit attributable to non-controlling interests - ordinary shares






-

Profit for the period attributable to equity shareholders of abrdn plc






165

Profit attributable to other equity holders






6

Profit attributable to non-controlling interests - ordinary shares






-

Profit for the period






171

Net operating revenue is reported as the measure of revenue in the analysis of adjusted operating profit and relates to revenues generated from external customers.



Investments

restated1

Adviser

ii2

Other

restated1

Total

6 months 2023

Notes

£m

£m

£m

£m

£m

Net operating revenue

4.4

461

103

152

5

721

Adjusted operating expenses


(427)

(54)

(91)

(22)

(594)

Adjusted operating profit


34

49

61

(17)

127

Adjusted net financing costs and investment return






 

24

Adjusted profit before tax






151

Tax on adjusted profit






(24)

Adjusted profit after tax






127

Adjusted for the following items







Restructuring and corporate transaction expenses

4.6





 

(113)

Amortisation and impairment of intangible assets acquired in business combinations and through the purchase of customer contracts

4.6





 

 

 

(102)

Change in fair value of significant listed investments

4.5





 

(181)

Dividends from significant listed investments

4.5





 

37

Share of profit or loss from associates and joint ventures






 

4

Other

4.9





35

Total adjusting items including results of associates and joint ventures






 

(320)

Tax on adjusting items






48

Profit attributable to other equity holders






(6)

Profit attributable to non-controlling interests - ordinary shares






 

-

Loss for the period attributable to equity shareholders of abrdn plc






 

(151)

Profit attributable to other equity holders






6

Profit attributable to non-controlling interests - ordinary shares






 

-

Loss for the period






(145)

1.  The breakdown of Investments and Other for the six months ended 30 June 2023 has been restated in line with the changes to the Group's reportable segments. Refer Note 4.3(a)(ii) for further details.

2.  Previously named Personal.

 

Full Year 2023

Notes

Investments

£m

Adviser

£m

ii

£m

Other

£m

Total

£m

Net operating revenue

4.4

878

224

287

9

1,398

Adjusted operating expenses


(828)

(106)

(173)

(42)

(1,149)

Adjusted operating profit


50

118

114

(33)

249

Adjusted net financing costs and investment return






 

81

Adjusted profit before tax






330

Tax on adjusted profit






(50)

Adjusted profit after tax






280

Adjusted for the following items







Restructuring and corporate transaction expenses

4.6





 

(152)

Amortisation and impairment of intangible assets acquired in business combinations and through the purchase of customer contracts

4.6





 

 

 

(189)

Profit on disposal of subsidiaries and other operations

4.2(b)





 

79

Change in fair value of significant listed investments

4.5





 

(178)

Dividends from significant listed investments

4.5





 

64

Share of profit or loss from associates and joint ventures






 

1

Reversal of impairment of interests in joint ventures

4.12





 

2

Other

4.9





37

Total adjusting items including results of associates and joint ventures






 

(336)

Tax on adjusting items






68

Profit attributable to other equity holders






(11)

Profit attributable to non-controlling interests - ordinary shares






 

-

Profit for the year attributable to equity shareholders of abrdn plc






 

1

Profit attributable to other equity holders






11

Profit attributable to non-controlling interests - ordinary shares






 

-

Profit for the year






12

 

4.4   Net operating revenue

(a)      Revenue from contracts with customers

The following table provides a breakdown of total revenue from contracts with customers.


6 months
2024

6 months

2023

restated2

Full Year

 2023


£m

£m

£m

Investments




Management fee income - Institutional and Retail Wealth1

344

399

769

Management fee income - Insurance Partners1

70

75

132

Performance fees and carried interest

7

12

18

Other revenue from contracts with customers

11

13

27

Revenue from contracts with customers for the Investments segment

432

499

946

Adviser




Platform charges

97

85

184

Treasury income

17

15

31

Other revenue from contracts with customers

6

4

11

Revenue from contracts with customers for the Adviser segment

120

104

226

ii3




Fee income - Advice and Discretionary

13

37

57

Account fees

26

27

54

Trading transactions

33

25

48

Treasury income

68

66

134

Revenue from contracts with customers for the ii segment3

140

155

293

Revenue from contracts with customers for Other

5

5

9

Total revenue from contracts with customers

697

763

1,474

1.  In addition to revenues earned as a percentage of AUM, management fee income includes certain other revenues not based on a percentage of AUM.

2.  The breakdown of revenue from contracts with customers for the six months ended 30 June 2023 has been restated in line with the changes to the Group's reportable segments. Refer Note 4.3(a)(ii) for further details.

3.  Previously named Personal.

(b)      Cost of sales

The following table provides a breakdown of total cost of sales.

 

6 months
2024

6 months

2023

Full Year

 2023

 

£m

£m

£m

Cost of sales




Commission expenses

22

33

64

Other cost of sales

8

9

12

Total cost of sales

30

42

76

Other cost of sales includes amounts payable to employees and others relating to carried interest and performance fee revenue.

(c)      Reconciliation of revenue from contracts with customers to net operating revenue as presented in the analysis of adjusted operating profit

The following table provides a reconciliation of revenue from contracts with customers as presented in the condensed consolidated income statement to net operating revenue, as presented in the analysis of adjusted operating profit (refer Note 4.3(b)(i) for each of the Group's reportable segments).


Investments

Adviser

ii

Other

Total


6 months 2024

6 months 2023

restated1

Full Year 2023

6 months 2024

6 months 2023

Full Year 2023

6 months 2024

6 months 2023

Full Year 2023

6 months 2024

6 months 2023

restated1

Full Year 2023

6 months 2024

6 months 2023

Full Year 2023


£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Revenue from contracts with customers

432

499

946

120

104

226

140

155

293

5

5

9

697

763

1,474

Cost of sales

(26)

(38)

(68)

(1)

(1)

(2)

(3)

(3)

(6)

-

-

-

(30)

(42)

(76)

Net operating revenue

406

461

878

119

103

224

137

152

287

5

5

9

667

721

1,398

1.  The breakdown of Investments and Other for the six months ended 30 June 2023 has been restated in line with the changes to the Group's reportable segments. Refer Note 4.3(a)(ii) for further details.

There are no differences between net operating revenue as presented in the condensed consolidated income statement and the analysis of Group adjusted profit by segment.

4.5   Net gains or losses on financial instruments and other income


6 months

2024

6 months

2023

Full Year

2023


£m

£m

£m

Fair value movements and dividend income on significant listed investments




Fair value movements on significant listed investments (other than dividend income)

(15)

 

(181)

(178)

Dividend income from significant listed investments

28

37

64

Total fair value movements and dividend income on significant listed investments

13

(144)

(114)

 




Non-unit linked business - excluding significant listed investments




Net gains or losses on financial instruments at fair value through profit or loss

23

(11)

6

Interest and similar income from financial instruments at amortised cost

37

30

76

Foreign exchange gain or losses on financial instruments at amortised cost

(2)

(5)

(7)

Other income

15

9

37

Net gains or losses on financial instruments and other income - non-unit linked business - excluding significant listed investments

73

 

23

112

Unit linked business




Net gains or losses on financial instruments at fair value through profit or loss




Net gains or losses on financial assets at fair value through profit or loss

43

44

69

Change in non-participating investment contract financial liabilities

(44)

(36)

(65)

Change in liability for third party interests in consolidated funds

-

(6)

(1)

Total net gains or losses on financial instruments at fair value through profit or loss

(1)

2

3

Interest and similar income from financial instruments at amortised cost

-

1

1

Net gains or losses on financial instruments and other income - unit linked business1

(1)

3

4

Total other net gains or losses on financial instruments and other income

72

26

116





Total net gains or losses on financial instruments and other income

85

(118)

2

1.  In addition to the Net gains or losses on financial instruments and other income - unit linked business of £(1)m (six months ended 30 June 2023: £3m, 12 months ended 31 December 2023: £4m), there are administrative expenses and policyholder tax of less than £1m (six months ended 30 June 2023: less than £1m, 12 months ended 31 December 2023: £1m) and £(1)m (six months ended 30 June 2023: £3m, 12 months ended 31 December 2023: £3m) respectively. The result attributable to unit linked business for the period is therefore £nil (six months ended 30 June 2023: £nil, 12 months ended 31 December 2023: £nil).

4.6   Administrative and other expenses


6 months

2024

6 months

2023

Full Year

2023


£m

£m

£m

Restructuring and corporate transaction expenses

51

113

152

Impairment of intangibles acquired in business combinations and through the purchase of customer contracts




Impairment of intangibles acquired in business combinations

5

37

63

Amortisation of intangibles acquired in business combinations and through the purchase of customer contracts




Amortisation of intangibles acquired in business combinations

54

59

115

Amortisation of intangibles acquired through the purchase of customer contracts

5

 

6

11

Total amortisation of intangibles acquired in business combinations and through the purchase of customer contracts

59

 

65

126

Staff costs and other employee-related costs

263

275

529

Other administrative expenses

295

274

593

Total administrative and other expenses1

673

764

1,463

1.  Total administrative and other expenses includes less than £1m (six months ended 30 June 2023: less than £1m, 12 months ended 31 December 2023: £1m) relating to unit linked business.

There were restructuring expenses of £45m (six months ended 30 June 2023: £90m, 12 months ended 31 December 2023: £121m), mainly consisting of costs to effect our cost transformation programme, including related severance expenses, and platform transformation expenses. The restructuring expenses for the 12 months ended 31 December 2023 were partly offset by a £32m release of the provision for separation costs. Refer Note 4.18 for further details. Corporate transaction expenses were £6m (six months ended 30 June 2023: £23m, 12 months ended 31 December 2023: £31m).

 

4.7   Tax expense

 


6 months

2024

6 months

2023

Full Year

2023


£m

£m

£m

Current tax:




UK

10

8

17

Pillar Two Top-up tax

1

-

-

Overseas

3

47

51

Adjustment to tax expense in respect of prior years

(1)

-

(2)

Total current tax

13

55

66

Deferred tax:




Deferred tax credit arising from the current period1

2

(65)

(69)

Adjustment to deferred tax in respect of prior years

1

(14)

(15)

Total deferred tax

3

(79)

(84)

Total tax expense/(credit)2

16

(24)

(18)

1.  The Group applies the exception to recognising and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes.

2.  The tax expense of £16m (six months ended 30 June 2023: tax credit of £24m, 12 months ended 31 December 2023: tax credit of £18m) includes a tax credit of £1m (six months ended 30 June 2023: tax expense of £3m, 12 months ended 31 December 2023: tax expense of £3m) relating to unit linked business.

Tax relating to components of other comprehensive income is as follows:


6 months

2024

6 months

2023

Full Year

2023


£m

£m

£m

Tax relating to fair value gains and losses recognised on cash flow hedges

2

(3)

(10)

Tax relating to cash flow hedge gains and losses transferred to condensed consolidated income statement

(2)

 

7

7

Equity holder tax effect relating to items that may be reclassified subsequently to
profit or loss

-

 

4

(3)

Tax relating to other comprehensive income

-

4

(3)

All of the amounts presented above are in respect of equity holders of abrdn plc.

Tax relating to items taken directly to equity is as follows:


6 months

2024

6 months

2023

Full Year

2023


£m

£m

£m

Tax relating to share-based payments

1

(2)

-

Tax relating to items taken directly to equity

1

(2)

-

 

4.8   Earnings per share

Basic earnings per share is calculated by dividing profit or loss attributable to ordinary equity holders by the weighted average number of ordinary shares in issue during the period excluding shares owned by the employee trusts that have not vested unconditionally to employees.

Diluted earnings per share is calculated by adjusting the weighted average number of ordinary shares in issue during the period to assume the conversion of all dilutive potential ordinary shares, such as share options granted to employees.

Adjusted earnings per share is calculated on adjusted profit after tax attributable to ordinary equity holders of the Company.

The following table shows details of basic, diluted and adjusted earnings per share.


6 months

2024

6 months

2023

Full Year

2023


£m

£m

£m

Adjusted profit before tax

170

151

330

Tax on adjusted profit

(41)

(24)

(50)

Adjusted profit after tax

129

127

280

Attributable to:



 

Other equity holders

(6)

(6)

(11)

Non-controlling interests - ordinary shares

-

-

-

Adjusted profit after tax attributable to equity shareholders of abrdn plc

123

121

269

Total adjusting items including results of associates and joint ventures

17

(320)

(336)

Tax on adjusting items

25

48

68

Profit/(loss) attributable to equity shareholders of abrdn plc

165

(151)

1

 


6 months

2024

6 months

2023

Full Year

2023


Millions

Millions

Millions

Weighted average number of ordinary shares outstanding

1,794

1,949

1,902

Dilutive effect of share options and awards

22

25

28

Weighted average number of diluted ordinary shares outstanding

1,816

1,974

1,930

In accordance with IAS 33, no share options and awards were treated as dilutive for the six months ended 30 June 2023 due to the loss attributable to equity holders of abrdn plc in this period. This resulted in the diluted earnings per share and adjusted diluted earnings per share for the six months ended 30 June 2023 being calculated using a weighted average number of ordinary shares of 1,949 million.


6 months

2024

6 months

2023

Full Year

2023


Pence

Pence

Pence

Basic earnings per share

9.2

(7.7)

0.1

Diluted earnings per share

9.1

(7.7)

0.1

Adjusted earnings per share

6.9

6.2

14.1

Adjusted diluted earnings per share

6.8

6.2

13.9

4.9   Adjusted profit and adjusting items

Adjusted profit excludes the impact of the following items:

-    Restructuring and corporate transaction expenses. Restructuring includes the impact of major regulatory change.

-    Amortisation and impairment of intangible assets acquired in business combinations and through the purchase of customer contracts.

-    Profit or loss arising on the disposal of a subsidiary, joint venture or equity accounted associate.

-    Change in fair value of/dividends from significant listed investments (refer Section 4.9(a) below).

-    Share of profit or loss from associates and joint ventures.

-    Impairment loss/reversal of impairment loss recognised on investments in associates and joint ventures accounted for using the equity method.

-    Fair value movements in contingent consideration.

-    Items which are one-off and, due to their size or nature, are not indicative of the long-term operating performance of the Group.

The tax expense or credit allocated to adjusting items is based on the tax treatment of each adjusting item.

The operating, investing and financing cash flows presented in the condensed consolidated statement of cash flows are for both adjusting and non-adjusting items.

(a)      Significant listed investments

Following the sale of the Group's final investments in HDFC Life and HDFC Asset Management in May 2023 and June 2023 respectively, the Group has one remaining significant listed investment, Phoenix.

Fair value movements on significant listed investments are included as adjusting items, which is aligned with our treatment of gains on disposal for these holdings when they were classified as associates. Dividends from significant listed investments are also included as adjusting items, as these result in fair value movements.

(b)      Other

Other adjusting items for the six months ended 30 June 2024 include:

-    A £12m gain (six months ended 30 June 2023: £5m gain, 12 months ended 31 December 2023: £23m gain) for net fair value movements in contingent consideration.

-    A £2m fair value gain (six months ended 30 June 2023: £5m loss, 12 months ended 31 December 2023: £5m loss) on a financial instrument liability related to a prior period acquisition.

-    A gain of £5m (six months ended 30 June 2023: £nil, 12 months ended 31 December 2023: gain of £4m) in relation to market gains and losses on the investments held by the abrdn Financial Fairness Trust which is consolidated by the Group. The assets of the abrdn Financial Fairness Trust are restricted to be used for charitable purposes.

-    A £15m release to Other administrative expenses of the prepayment recognised in relation to the Group's purchase of Phoenix's trustee investment plan business for UK pension scheme clients. Refer Note 4.14 for further details.

Other adjusting items for the six months ended 30 June 2023 and the 12 months ended 31 December 2023 included:

-    £36m for an insurance liability recovery in relation to the single process execution event in 2022. The £41m provision expense was included in other adjusting items for the 12 months ended 31 December 2022.

Other adjusting items for the 12 months ended 31 December 2023 also included:

-    £21m for provision expense relating to a potential tax liability. Refer Note 4.18.

 

4.10 Dividends on ordinary shares


6 months 2024

6 months 2023

Full Year 2023


Pence per
share

£m1

Pence per
share

£m

Pence per
share

£m

Dividends paid in reporting period







Current year interim dividend

-

-

-

-

7.30

137

Final dividend for prior year

7.30

130

7.30

142

7.30

142

Total dividends paid in reporting period


130


142


279








Dividends relating to reporting period







Interim dividend

7.30

130

7.30

137

7.30

137

Final dividend

-

-

-

-

7.30

130

Total dividends relating to reporting period


130


137


267

1.  Estimated for the current period interim recommended dividend.

Subsequent to 30 June 2024, the Board has declared an interim dividend for 2024 of 7.30 pence per ordinary share (interim 2023: 7.30 pence), an estimated £130m in total (interim 2023: £137m). The dividend is expected to be paid on 24 September 2024 and will be recorded as an appropriation of retained earnings in the financial statements for the year ended 31 December 2024.

4.11 Intangible assets

 

 

30 Jun

2024

30 Jun

2023

31 Dec

2023


£m

£m

£m

Acquired through business combinations



 

Goodwill

907

898

912

Brand

10

12

11

Customer relationships and investment management contracts

530

555

579

Technology and other

10

20

15

Internally developed software

14

12

13

Cost of obtaining customer contracts

43

51

48

Total intangible assets

1,514

1,548

1,578

Goodwill at 30 June 2024 comprises a gross carrying value of £4,704m (30 June 2023: £4,665m, 31 December 2023: £4,704m) and accumulated impairment of £3,797m (30 June 2023: £3,767m, 31 December 2023: £3,792m).

There were no additions to intangibles acquired through business combinations in the six months ended 30 June 2024 or the six months ended 30 June 2023. The additions to intangibles acquired through business combinations for the 12 months ended 31 December 2023 related to the acquisition of the healthcare fund management capabilities of Tekla. Refer Note 4.2(a)(i) for further details.

During the six months ended 30 June 2024, the Group recognised an impairment of the goodwill relating to the Finimize cash-generating unit (CGU) which is reported within Other business operations and corporate costs of £5m. Following this impairment, the goodwill allocated to the Finimize CGU is now fully impaired (30 June 2023: £17m, 31 December 2023: £5m). The impairment reflects higher anticipated losses in the period prior to which abrdn anticipates Finimize is likely to achieve profitability and the related Group support required in this period.

The recoverable amount of the Finimize CGU at 30 June 2024 was £10m which was based on fair value less costs of disposal (FVLCD). The FVLCD considered a number of valuation approaches, with the primary approach being a revenue multiple approach. The key assumptions used in determining the revenue multiple valuation were future revenue projections, which were based on management forecasts and market multiples for broadly comparable listed companies, with appropriate discounts applied to take into account profitability, track record, revenue growth potential, and net premiums for control. This is a level 3 measurement as they are measured using inputs which are not based on observable market data.

During the 12 months ended 31 December 2023 and six months ended 30 June 2023, the Group recognised impairments of goodwill of £62m and £37m respectively. In the 12 months ended 31 December 2023, the Group also recognised an impairment of the goodwill relating to the Finimize CGU of £26m for the 12 months ended 31 December 2023 of which £14m was also recognised for the six months ended 30 June 2023. In addition, the Group recognised an impairment of the goodwill relating to the abrdn Financial Planning Limited (aFPL) CGU which is included in the ii segment of £36m of which £23m was also recognised for the six months ended 30 June 2023.

4.12 Investments in associates and joint ventures accounted for using the equity method

 

 

30 Jun

2024

30 Jun

2023

31 Dec

2023


£m

£m

£m

Associates



 

Other

15

15

15

Joint ventures




HASL

183

223

214

Other

-

7

-

Total investments in associates and joint ventures accounted for using the equity method

198

245

229

There were no additions to associates accounted for using the equity method during the six months ended 30 June 2024. During the six months ended 30 June 2023 and the 12 months ended 31 December 2023, the Group made additions to Other associates accounted for using the equity method of £2m.

There were no additions to joint ventures accounted for using the equity method (six months ended 30 June 2023: none, 12 months ended 31 December 2023: none).

The share of profit or loss and other comprehensive income from associates and joint ventures for the six months ended 30 June 2024 of £21m (six months ended 30 June 2023: £4m, 12 months ended 31 December 2023: £1m) and £(49)m (six months ended 30 June 2023: £(18)m, 12 months ended 31 December 2023: £(31)m) respectively primarily relates to HASL.

The carrying value of joint ventures accounted for using the equity method for Other at 30 June 2023 primarily related to the Group's interest in Virgin Money UTM which was transferred to held for sale at 31 December 2023. Refer Note 4.15 below. Prior to the transfer, a reversal of prior impairment of the Group's interest of £2m was recognised. The reversal of impairment was included in Reversal of impairment of interests in joint ventures in the condensed consolidated income statement for the 12 months ended 31 December 2023 (six months ended 30 June 2024: £nil, six months ended 30 June 2023: £nil). The interest in Virgin Money UTM did not form part of the Group's reportable segments.

4.13 Property, plant and equipment

 

 

30 Jun

2024

30 Jun

2023

31 Dec

 2023


£m

£m

£m

Owner occupied property

-

1

1

Equipment

44

45

46

Right-of-use assets - property

105

115

115

Right-of-use assets - equipment

1

1

1

Total property, plant and equipment

150

162

163

No impairments of or reversal of impairments for right-of-use assets for property have been recognised in the six months ended 30 June 2024.

For the six months ended 30 June 2023 and the 12 months ended 31 December 2023 impairments of £35m and £39m were recognised respectively. The impairments related to a number of properties in the UK and the US that are no longer being used operationally by the Group. The right-of-use assets are related to the Investments segment (six months ended 30 June 2023 and 12 months ended 31 December 2023: £27m impairment), the ii segment (six months ended 30 June 2023 and 12 months ended 31 December 2023: £1m impairment) and Other business operations and corporate costs (six months ended 30 June 2023: £7m impairment, 12 months ended 31 December 2023: £11m impairment).

For the six months ended 30 June 2023 and the 12 months ended 31 December 2023 the Group also recognised a reversal of impairment of £3m in relation to a property in the UK which was not being used operationally but following the review of properties in the UK was brought back into operational use. The right-of-use asset is related to the Investments segment.

4.14 Other assets

Other assets of £74m (30 June 2023: £100m, 31 December 2023: £77m) includes prepayments of £7m (30 June 2023: £30m, 31 December 2023: £23m) which relate to the Group's purchase of certain products in Phoenix's savings business offered through abrdn's Wrap platform together with Phoenix's trustee investment plan (TIP) business for UK pension scheme clients. Refer Note 4.21(b) for further details.

During the six months ended 30 June 2024, the Group has released £15m of the £19m prepayment recognised in relation to the TIP business to Other administrative expenses in the condensed consolidated income statement following a review of the recoverability of these costs from future profits from the TIP business. The transfer of this business to the Group is now expected to occur in 2025.

4.15 Assets and liabilities held for sale


30 Jun

2024

30 Jun

2023

31 Dec

2023


£m

£m

£m

Assets of operations held for sale




threesixty services

6

-

-

abrdn Capital Limited

-

83

-

European-headquartered Private Equity business

-

-

10

Investment Vehicles

5

-

-

Investments in joint ventures accounted for using the equity method




Virgin Money UTM

-

-

9

Assets held for sale

11

83

19

Liabilities of operations held for sale




threesixty services

2

-

-

abrdn Capital Limited

-

6

-

European-headquartered Private Equity business

-

-

2

Liabilities of operations held for sale

2

6

2

The assets and liabilities of operations held for sale (excluding investment vehicles) at 30 June 2024 relate to the sale of the Group's threesixty services business which completed on 2 July 2024. Refer Note 4.23 for further details. The threesixty services business net assets classified as held for sale which were measured at their carrying values were net of intercompany balances between the business and other Group entities. The net assets on a gross basis were also £4m.

In relation to assets and liabilities held for sale at 31 December 2023 and 30 June 2023.

-    The sale of the Group's European-headquartered Private Equity business completed on 26 April 2024. Refer Note 4.2(b)(i) for further details.

-    The sale of the Group's interest in Virgin Money UTM completed on 2 April 2024. Refer Note 4.2(b)(ii) for further details.

-    The sale of abrdn Capital Limited completed on 1 September 2023. Refer Note 4.2(b)(iii) for further details.

4.16 Issued share capital and share premium, shares held by trusts, retained earnings and other reserves

(a)      Issued share capital and share premium

The movement in the issued ordinary share capital and share premium of the Company was:


6 months 2024

6 months 2023

Full Year 2023


Ordinary share capital

Share premium

Ordinary share capital

Share premium

Ordinary share capital

Share premium

Issued shares fully paid

13 61/63p each

£m

£m

13 61/63p each

£m

£m

13 61/63p each

£m

£m

At start of period

1,840,740,364

257

640

2,001,891,899

280

640

2,001,891,899

280

640

Shares issued in respect of share incentive plans

1,120

-

-

 

1,023

 

-

 

-

2,414

 

-

 

-

Shares bought back on-market and cancelled

-

-

-

 

(39,587,562)

 

(6)

 

-

(161,153,949)

(23)

-

At end of period

1,840,741,484

257

640

1,962,305,360

274

640

1,840,740,364

257

640

All ordinary shares in issue in the Company rank pari passu and carry the same voting rights and entitlement to receive dividends and other distributions declared or paid by the Company.

During the six months to 30 June 2024 the Group has not undertaken any share buybacks.

During 2023, the Group undertook a £300m share buyback programme. The share buyback commenced on 5 June 2023 and was completed on 19 December 2023.

-    During the six months to 30 June 2023, the Company had bought back and cancelled 39,587,562 shares for a total consideration of £98m which included transaction costs and unsettled purchases for 6,138,236 shares.

-    During the 12 months ended 31 December 2023, the Company had bought back and cancelled 161,153,949 shares for a total consideration of £302m which included transaction costs.

The share buyback resulted in a reduction in retained earnings in the six months ended 30 June 2023 and the 12 months ended 31 December 2023 of £98m and £302m respectively. In addition, £6m and £23m respectively were credited to the capital redemption reserve relating to the nominal value of the shares cancelled for these periods.

The Company can issue shares to satisfy awards granted under employee incentive plans which have been approved by shareholders.

(b)      Shares held by trusts

Shares held by trusts relates to shares in abrdn plc that are held by the abrdn Employee Benefit Trust (abrdn EBT), abrdn Employee Trust (abrdn ET) and the Aberdeen Asset Management Employee Benefit Trust 2003 (AAM EBT).

The abrdn EBT, abrdn ET and AAM EBT purchase shares in the Company for delivery to employees under employee incentive plans. Purchased shares are recognised as a deduction from equity at the price paid for them. Where new shares are issued to the abrdn EBT, abrdn ET or AAM EBT the price paid is the nominal value of the shares. When shares are distributed from the trust their corresponding value is released to retained earnings.

The number of shares held by trusts was as follows:



30 Jun

2024

30 Jun

2023

31 Dec

2023

Number of shares held by trusts





abrdn Employee Benefit Trust


32,299,515

35,540,771

34,076,343

abrdn Employee Trust


22,032,503

22,270,081

22,187,644

Aberdeen Asset Management Employee Benefit Trust 2003


1,926,756

2,194,934

2,080,853

(c)      Retained earnings and other reserves

The merger reserve includes £94m (30 June 2023: £263m, 31 December 2023: £94m) in relation to the Group's asset management businesses. Following the impairment of the Company's investment in abrdn Investments (Holdings) Limited, £169m was transferred from the merger reserve to retained earnings during the 12 months ended 31 December 2023.

There were no transfers from the merger reserve to retained earnings during the six months ended 30 June 2024 and the six months ended 30 June 2023.

4.17 Pension and other post-retirement benefit provisions

The Group operates a number of defined benefit pension plans, the largest of which is the abrdn UK Group plan (principal plan) which is closed to future accrual. The Group also operates two other UK defined benefit plans, which are closed to future accrual, the abrdn ROI plan, which has two employees accruing future benefits, and a number of smaller funded and unfunded defined benefit plans in other countries.

For the UK plans, the trustees set the plan investment strategies to protect the ratio of plan assets to the trustees' measure of the value of assets needed to meet the trustees' objectives. The investment strategies do not aim to protect an IAS 19 surplus or ratio of plan assets to the IAS 19 measure of liabilities.

(a)      Analysis of amounts recognised in the condensed consolidated income statement

The amounts recognised in the condensed consolidated income statement for defined contribution and defined benefit plans are as follows:


6 months

2024

6 months

2023

Full Year

2023


£m

£m

£m

Current service cost

24

28

55

Past service cost

-

(5)

(5)

Net interest income

(16)

(18)

(38)

Administrative expenses

9

2

4

Expense recognised in the condensed consolidated income statement

17

7

16

In addition, for the six months ended 30 June 2024, gains of £72m (six months ended 30 June 2023: losses of £81m, 12 months ended 31 December 2023: losses of £139m) have been recognised in other comprehensive income in the condensed consolidated statement of comprehensive income in relation to remeasurement of the defined benefit plans.

(b)      Analysis of amounts recognised in the condensed consolidated statement of financial position

Pension and other post-retirement benefit assets at 30 June 2024 of £821m (30 June 2023: £772m, 31 December 2023: £740m) includes the following amounts in relation to the principal plan:


30 Jun

2024

30 Jun

2023

31 Dec

 2023


£m

£m

£m

Present value of funded obligation

(1,650)

(1,664)

(1,784)

Fair value of plan assets

2,736

2,819

2,912

Net asset before the limit on plan surplus

1,086

1,155

1,128

Effect of limit on plan surplus1

(271)

(404)

(394)

Net asset

815

751

734

1.  UK recoverable surpluses are reduced to reflect an authorised surplus payments charge of 25% that would arise on a refund. This charge was reduced from 35% to 25% effective from 6 April 2024 and this is reflected in the net asset at 30 June 2024. The comparative figures at 30 June 2023 and 31 December 2023 are shown with a 35% surplus charge.

A pension plan surplus is considered to be recoverable where an unconditional right to a refund exists.

We are continuing to work with the trustee on the long-term strategy for the plan, including steps relating to any residual surplus assets that remain after all plan related obligations are settled or otherwise provided for. The timing for implementing any strategy, including the release of any surplus, remains a matter for the trustee. See Note 31 in the Annual report and accounts 2023 for more information.

(c)      Principal assumptions

Determination of the valuation of principal plan liabilities is a key estimate as a result of the assumptions made relating to both economic and non-economic factors.

The key economic assumptions for the principal plan, which are based in part on current market conditions, are shown below:


30 Jun

2024

30 Jun

2023

31 Dec

2023


%

%

%

Discount rate

5.25

5.25

4.60

Rates of inflation




Consumer Price Index (CPI)

2.80

2.80

2.65

Retail Price Index (RPI)

3.15

3.15

3.00

The changes in economic assumptions over the period reflect changes in both corporate bond prices and market implied inflation. The underlying methodology used to set these key economic assumptions has not changed over the reporting period. The population of corporate bond prices excludes bonds issued by UK universities. The inflation assumption reflects the future reform of RPI effective from 2030.

The determination of the present value of the funded obligation at 30 June 2024 includes a methodology change for post-retirement pension increases on 'post 6th April 88' GMP pensions in the principal plan. The previous methodology used a deterministic approach in line with the relevant CPI index. The updated methodology allows for the contractual pension increase cap and floor when deriving the pension increase assumption, using an assumed CPI inflation volatility of 2% p.a. The impact of this methodology change is to reduce the closing obligation by c.£6m.

4.18 Provisions

 

 

30 Jun

2024

30 Jun

2023

31 Dec

2023


£m

£m

£m

Provisions



 

Separation costs

-

32

-

Tax related provisions

42

-

42

Other provisions

20

26

24

Total provisions

62

58

66

The separation cost provision recognised at 30 June 2023 of £32m was in respect of costs expected to be incurred following the sale of the UK and European insurance business to Phoenix. Following the completion of the separation programme during the 12 months ended 31 December 2023 the Group expected no further costs to be incurred and £32m was released from the provision.

The provision for a potential liability of £42m relates to a disputed tax matter which is the subject of an ongoing appeal. Any resolution is not expected to be until 2025 at the earliest. A reimbursement asset has been recognised within receivables and other financial assets for £18m (30 June 2023: £nil, 31 December 2023: £18m) which is an expected recovery in the event of any settlement.

4.19 Fair value of assets and liabilities

(a)      Fair value hierarchy

In determining fair value, the following fair value hierarchy categorisation has been used:

-   Level 1: Fair values measured using quoted prices (unadjusted) in active markets for identical assets or liabilities. An active market exists where transactions take place with sufficient frequency and volume to provide pricing information on an ongoing basis.

-   Level 2: Fair values measured using inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).

-   Level 3: Fair values measured using inputs that are not based on observable market data (unobservable inputs).

Information on the methods and assumptions used to determine fair values for equity securities and interests in pooled investment funds, debt securities and derivatives measured at fair value is given below:


Equities and interests in pooled investment funds1,2

Debt securities

Derivatives3

Level 1

Equity instruments listed on a recognised exchange valued using prices sourced from their primary exchange.

Debt securities listed on a recognised exchange valued using prices sourced from their primary exchange.

Exchange traded derivatives valued using prices sourced from the relevant exchange.

Level 2

Pooled investment funds where daily unit prices are available and reference is made to observable market data.

Debt securities valued using prices received from external pricing providers based on quotes received from a number of market participants.

 

Debt securities valued using models and standard valuation formulas based on observable market data4.

Over-the-counter derivatives measured using a range of valuation models including discounting future cash flows and option valuation techniques.

Level 3

These relate primarily to interests in private equity, real estate and infrastructure funds which are valued at net asset value. Underlying real estate and private equity investments are generally valued in accordance with independent professional valuation reports or International Private Equity and Venture Capital Valuation Guidelines where relevant. The underlying investments in infrastructure funds are generally valued based on the phase of individual projects forming the overall investment and discounted cash flow techniques based on project earnings.

 

Where net asset values are not available at the same date as the reporting date, the latest available valuations are reviewed and, where appropriate, adjustments are made to reflect the estimated impact of changes in market conditions between the date of the valuation and the end of the reporting period.

 

Other unlisted equity securities are generally valued using a calibration to the price of a recent investment.

Debt securities valued using prices received from external pricing providers based on a single broker indicative quote.

 

Debt securities valued using models and standard valuation formulas based on unobservable market data4.

N/A

1.  Investments in associates at fair value through profit or loss are valued in the same manner as the Group's equity securities and interests in pooled investment funds.

2.  Where pooled investment funds have been seeded and the investment in the funds have been classified as held for sale, the costs to sell are assumed to be negligible. The fair value of pooled investment funds held for sale is calculated as equal to the observable unit price.

3.  Non-performance risk arising from the credit risk of each counterparty is also considered on a net exposure basis in line with the Group's risk management policies. At 30 June 2024, 30 June 2023 and 31 December 2023, the residual credit risk is considered immaterial and no credit risk adjustment has been made.

4.  If prices are not available from the external pricing providers or are considered to be stale, the Group has established procedures to arrive at an internal assessment of the fair value.

The fair value of liabilities in respect of third party interest in consolidated funds and non-participating investment contracts are calculated equal to the fair value of the underlying assets and liabilities.

Thus, the value of these liabilities is dependent on the methods and assumptions set out above in relation to the underlying assets and liabilities:

-    For third party interest in consolidated funds, when the underlying assets and liabilities are valued using readily available market information the liabilities in respect of third party interest in consolidated funds are treated as level 2. Where the underlying assets and liabilities are not valued using readily available market information the liabilities in respect of third party interest in consolidated funds are treated as level 3.

-   For non-participating investment contracts, the underlying assets and liabilities are predominately categorised as level 1 or 2 and as such, the inputs into the valuation of the liabilities are observable and these liabilities are predominately categorised within level 2 of the fair value hierarchy. Where the underlying assets are categorised as level 3, the liabilities are also categorised as level 3.

In addition, contingent consideration assets and contingent consideration liabilities are also categorised as level 3 in the fair value hierarchy. Contingent consideration assets and liabilities have been recognised in respect of acquisitions and disposals. Generally valuations are based on unobservable assumptions regarding the probability weighted cash flows and, where relevant, discount rate.

(b)      Fair value hierarchy for assets and liabilities measured at fair value other than assets backing unit linked liabilities and unit linked liabilities

(b)(i)  Fair value hierarchy for assets measured at fair value in the statement of financial position other than assets backing unit linked liabilities

The table below presents the Group's non-unit linked assets measured at fair value by level of the fair value hierarchy (refer Section 4.19(c) for fair value analysis in relation to assets backing unit linked liabilities).








Fair value hierarchy


As recognised in the condensed consolidated statement of financial position

Classified as held for sale

Total

Level 1

Level 2

Level 3


30 Jun

2024

30 Jun

2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023


£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Derivative financial assets

46

78

43

-

-

-

46

78

43

-

-

-

46

78

43

-

-

-

Equity securities and interests in pooled investment vehicles1

1,138

1,167

1,139

6

-

-

1,144

 

1,167

1,139

743

 

808

769

140

 

128

137

261

 

231

233

Debt securities2

735

734

740

-

-

-

735

734

740

6

2

7

728

731

732

1

1

1

Financial investments

1,919

1,979

1,922

6

-

-

1,925

1,979

1,922

749

810

776

914

937

912

262

232

234

Owner occupied property3

-

1

1

-

-

-

-

1

1

-

-

-

-

-

-

-

1

1

Contingent consideration assets4

21

24

11

-

-

-

21

24

11

-

-

-

-

-

-

21

24

11

Total assets at fair value

1,940

2,004

1,934

6

-

-

1,946

2,004

1,934

749

810

776

914

937

912

283

257

246

1.  Includes £542m (30 June 2023: £554m, 31 December 2023: £557m) for the Group's listed equity investment in Phoenix which is classified as a significant listed investment. The Group's listed equity investments in HDFC Asset Management and HDFC Life which were also classified as significant listed investments were sold in the six months ended 30 June 2023.

2.  There were no debt securities measured at amortised cost at 30 June 2024. Debt securities at fair value at 30 June 2023 and 31 December 2023 excluded debt securities measured at amortised cost of £101m and £125m respectively - refer Section 4.19(d).

3.  Presented in Property, plant and equipment in the condensed consolidated statement of financial position.

4.  Presented in Receivables and other financial assets in the condensed consolidated statement of financial position.

There were no significant transfers between level 1 and level 2 during the six months ended 30 June 2024 (six months ended 30 June 2023 and 12 months ended 31 December 2023: none). Transfers are deemed to have occurred at the end of the calendar quarter in which they arose.

Refer Section 4.19(b)(iii) below for details of movements in level 3.

(b)(ii) Fair value hierarchy for liabilities measured at fair value in the statement of financial position other than unit linked liabilities

The table below presents the Group's non-unit linked liabilities measured at fair value by level of the fair value hierarchy.



Fair value hierarchy


Total

Level 1

Level 2

Level 3


30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023


£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Liabilities in respect of third party interest in consolidated funds

206

 

212

187

-

 

-

 

-

137

 

141

117

69

 

71

70

Derivative financial liabilities

4

2

9

1

1

7

3

1

2

-

-

-

Contingent consideration liabilities1

100

129

114

-

-

-

-

-

-

100

129

114

Other financial liabilities2

13

16

15

-

-

-

-

-

-

13

16

15

Total liabilities at fair value

323

359

325

1

1

7

140

142

119

182

216

199

1.  Presented in Other financial liabilities in the condensed consolidated statement of financial position.

2.  Excluding contingent consideration liabilities.

There were no significant transfers between level 1 and level 2 during the six months ended 30 June 2024 (six months ended 30 June 2023 and 12 months ended 31 December 2023: none).

Refer Section 4.19(b)(iii) below for details of movements in level 3.

(b)(iii)   Reconciliation of movements in level 3 instruments

The movements during the period of level 3 assets and liabilities held at fair value, excluding unit linked assets and liabilities and assets and liabilities held for sale, are analysed below.


Owner occupied property

Equity securities and interests in

pooled investment funds

Debt securities

Liabilities in respect of third party interest in consolidated funds


30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023


£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

At start of period

1

1

1

233

231

231

1

2

2

(70)

(74)

(74)

Total gains recognised in the condensed consolidated income statement

-

-

-

3

1

1

-

-

-

-

-

-

Purchases

-

-

-

28

7

18

-

-

-

-

-

-

Sales and other adjustments

(1)

-

-

(2)

(2)

(17)

-

(1)

(1)

1

3

4

Foreign exchange adjustment

-

-

-

(1)

(6)

-

-

-

-

-

-

-

At end of period

-

1

1

261

231

233

1

1

1

(69)

(71)

(70)

 


Contingent consideration assets

Contingent consideration liabilities

Other financial liabilities1


30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023


£m

£m

£m

£m

£m

£m

£m

£m

£m

At start of period

11

19

19

(114)

(132)

(132)

(15)

(11)

(11)

Total amounts recognised in the condensed consolidated income statement

2

 

7

7

10

 

(2)

16

2

 

(5)

(5)

Additions

10

-

7

-

-

(11)

-

-

-

Settlements

(2)

(2)

(21)

4

4

12

-

-

1

Other movements

-

-

(1)

-

1

1

-

-

-

At end of period

21

24

11

(100)

(129)

(114)

(13)

(16)

(15)

1.  Excluding contingent consideration liabilities.

For the six months ended 30 June 2024, gains of £17m (six months ended 30 June 2023: gains of £1m, 12 months ended 31 December 2023: gains of £19m) were recognised in the condensed consolidated income statement in respect of non-unit linked assets and liabilities held at fair value classified as level 3 at the period end, excluding assets and liabilities held for sale. All gains were recognised in Net gains or losses on financial instruments and other income.

Transfers of equity securities and interests in pooled investment funds and debt securities into level 3 generally arise when external pricing providers stop providing a price or where the price provided is considered stale. Transfers of equity securities and interests in pooled investment funds and debt securities out of level 3 arise when acceptable prices become available from external pricing providers.

(b)(iv)   Significant unobservable inputs in level 3 instrument valuations

The table below identifies the significant unobservable inputs in relation to equity securities and interests in pooled investment funds categorised as level 3 instruments at 30 June 2024 with a fair value of £261m (30 June 2023: £231m, 31 December 2023: £233m).


Fair value





30 Jun 2024

£m

30 Jun 2023

£m

31 Dec 2023

£m

Valuation technique

Unobservable input

Range (weighted average)

Private equity, real estate, hedge and infrastructure funds

249

219

221

Net asset value

Net asset value statements provided for ten significant funds (fair value >£5m) and a large number of smaller funds

A range of unobservable inputs is not applicable as we have determined that the reported NAV represents fair value at the end of the reporting period

Other unlisted equity securities

12

12

12

Indicative share price

Calibration to the price of a recent investment.

A range of unobservable inputs is not applicable as we have determined that the calibration to the price of a recent investment represents fair value at the end of the reporting period.

The unobservable input for the Group's related liabilities in respect of third party interest in consolidated funds categorised as level 3 instruments at 30 June 2024 with a fair value of £(69)m (30 June 2023: £(71)m, 31 December 2023: £(70)m) are the same as for the private equity, real estate, hedge and infrastructure funds above. There are no single significant funds in relation to liabilities in respect of third party interest in consolidated funds.

The table below identifies the significant unobservable inputs in relation to contingent consideration assets and liabilities and other financial instrument liabilities categorised as level 3 instruments at 30 June 2024 with a fair value of £(92)m (30 June 2023: £(121)m, 31 December 2023: £(118)m).


Fair value





30 Jun 2024

£m

30 Jun 2023

£m

31 Dec 2023

£m

Valuation technique

Unobservable input

Range (weighted average)

Contingent consideration assets and liabilities and other financial instrument liabilities

(92)

(121)

(118)

Probability weighted cash flow and where applicable discount rates

Unobservable inputs relate to probability weighted cash flows and, where relevant, discount rates.

The most significant unobservable inputs relate to assumptions used to value the contingent consideration liability related to the acquisition of Tritax of £82m (30 June 2023: £109m, 31 December 2023: £90m). For Tritax a number of scenarios were prepared, around a base case, with probabilities assigned to each scenario (based on an assessment of the likelihood of each scenario). The scenarios allow for adjustments to the profit used to determine the contingent consideration under the sale purchase agreement. The value of the contingent consideration was determined for each scenario, and these were then probability weighted, with this probability weighted valuation then discounted from the payment date to the balance sheet date. It was assumed that the timing of the exercise of the earn out put options between 2024, 2025 and 2026 would be that which is most beneficial to the holders of the put options.

The base scenario for Tritax contingent consideration used a revenue compound annual growth rate (CAGR) from 31 March 2023 to 31 March 2026 of 9% (30 June 2023: CAGR from 31 March 2022 to 31 March 2026 of 14% and 31 December 2023: CAGR from 31 March 2023 to 31 March 2026 of 9%) with other scenarios using a range of revenue growth assumptions around this base. The base scenario used a cost/income ratio of c57% (30 June 2023: c52% and 31 December 2023: c56%) with other scenarios using a range of cost/income ratios around this base.

The risk adjusted contingent consideration cash flows have been discounted using a primary discount rate of 4% (30 June 2023: 5% and 31 December 2023: 4%).

(b)(v)    Sensitivity of the fair value of level 3 instruments to changes in key assumptions

At 30 June 2024, the shareholder is directly exposed to movements in the value of all non-unit linked level 3 instruments. Refer Section 4.19(c) for unit linked level 3 instruments.

Sensitivities for material level 3 assets and liabilities are provided below. Changing unobservable inputs in the measurement of the fair value of the other level 3 financial assets and financial liabilities to reasonably possible alternative assumptions would not have a material impact on profit attributable to equity holders or on total assets.

(b)(v)(i) Equity securities and interests in pooled investment funds

As noted above, of the level 3 equity securities and interests in pooled investment funds, £249m relates to private equity, real estate, hedge and infrastructure funds (30 June 2023: £219m, 31 December 2023: £221m) which are valued using net asset value statements. A 10% increase or decrease in the net asset value of these investments would increase or decrease the fair value of the investments by £25m.

(b)(v)(ii) Liabilities in respect of third party interest in consolidated funds

As noted above, £69m of liabilities in respect of third party interest in consolidated funds of the level 3 equity securities and interests in pooled investment funds (30 June 2023: £71m, 31 December 2023: £70m) are also valued using net asset value statements. A 10% increase or decrease in the net asset value of these investments would increase or decrease the fair value of the liability by £7m.

(b)(v)(iii) Contingent consideration assets and liabilities and other financial instrument liabilities

As noted above, the most significant unobservable inputs for level 3 instruments relate to assumptions used to value the contingent consideration related to the purchase of Tritax. Sensitivities for reasonably possible changes to key assumptions are provided in the table below.

Assumption

Change in assumption

Consequential increase/(decrease) in contingent consideration liability



30 Jun

2024

£m

Revenue compound annual growth rate (CAGR) from 31 March 2023 to 31 March 2026

Decreased by 5%

(14)


Increased by 10%

33

Cost/income ratio

Decreased by 5%

13


Increased by 5%

(13)

Discount rate

Decreased by 2%

3


Increased by 2%

(3)

(c)      Fair value hierarchy for assets backing unit linked liabilities and unit linked liabilities measured at fair value

The table below presents the Group's assets backing unit linked liabilities and unit linked liabilities measured at fair value by level of the fair value hierarchy.


Total

Fair value hierarchy

Level 1

Level 2

Level 3


30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023


£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Financial investments

655

873

669

362

590

396

293

283

273

-

-

-

Total assets at fair value backing unit linked liabilities

655

 

873

669

362

 

590

396

293

 

283

273

-

 

-

 

-

Investment contract liabilities

670

724

684

-

-

-

670

724

684

-

-

-

Third party interest in consolidated funds

-

 

165

 

-

-

 

-

 

-

-

 

165

 

-

-

 

-

 

-

Other unit linked liabilities1

-

1

-

-

-

-

-

1

-

-

-

-

Total unit linked liabilities at fair value

670

 

890

684

-

 

-

 

-

670

 

890

684

-

 

-

 

-

1.  Excludes other unit linked liabilities not measured at fair value of £8m (30 June 2023: £4m, 31 December 2023: £2m).

The financial investments backing unit linked liabilities comprise equity securities and interests in pooled investment funds of £652m (30 June 2023: £764m, 31 December 2023: £667m), debt securities of £3m (30 June 2023: £107m, 31 December 2023: £2m) and derivative financial assets of £nil (30 June 2023: £2m, 31 December 2023: £nil).

There were no significant transfers between level 1 and level 2 during the six months ended 30 June 2024 (six months ended 30 June 2023 and 12 months ended 31 December 2023: none).

The movements during the period of level 3 unit linked assets and liabilities held at fair value are analysed below.


Equity securities and interests in

pooled investment funds

Investment contract liabilities


30 Jun

2024

30 Jun

2023

31 Dec

 2023

30 Jun

2024

30 Jun

2023

31 Dec

 2023


£m

£m

£m

£m

£m

£m

At start of period

-

1

1

-

(1)

(1)

Sales

-

(1)

(1)

-

1

1

At end of period

-

-

-

-

Unit linked level 3 assets related to holdings in real estate funds.

(d)      Assets and liabilities not carried at fair value

The table below presents estimated fair values of non-unit linked financial assets and liabilities whose carrying value does not approximate fair value. Fair values of assets and liabilities are based on observable market inputs where available or are estimated using other valuation techniques.


As recognised in condensed consolidated statement of financial position line item

Fair value


30 Jun

2024

30 Jun

2023

31 Dec

2023

30 Jun

2024

30 Jun

2023

31 Dec

2023


£m

£m

£m

£m

£m

£m

Assets







Debt securities

-

101

125

-

101

125

Liabilities







Subordinated liabilities

604

588

599

555

515

534

The estimated fair values for subordinated liabilities are based on the quoted market offer price. The carrying value of all other financial assets and liabilities measured at amortised cost approximates their fair value.

4.20 Contingent liabilities and contingent assets

Legal proceedings, complaints and regulations

The Group is subject to regulation in all of the territories in which it operates investment management, asset administration  and insurance businesses. In the UK, where the Group primarily operates, the FCA has broad powers, including powers to investigate marketing and sales practices.

The Group, like other financial organisations, is subject to legal proceedings, complaints and regulatory and tax authority discussions and reviews in the normal course of its business. All such material matters are periodically reassessed, with the assistance of external professional advisers where appropriate, to determine the likelihood of the Group incurring a liability. Where it is concluded that it is more likely than not that a material outflow will be made a provision is established based on management's best estimate of the amount that will be payable. A subsidiary of the Group is currently responding to certain information requests from an overseas Tax Authority in connection with its Income Tax Returns. Interpretation of tax legislation is complex and therefore, as part of the normal course of business, local tax authorities may sometimes request further information in order to clarify facts and technical approach. These types of enquiries can sometimes be prolonged due to inherent complexity. At this stage of enquiry, it is not possible to reliably predict the outcome.

There are no other identified contingent liabilities expected to lead to a material exposure.

4.21 Commitments

(a)      Unrecognised financial instruments

As at 30 June 2024, the Group has committed to investing an additional £52m (30 June 2023: £74m, 31 December 2023: £67m) into funds in which it holds a co-investment interest.

(b)      Capital and other commitments

As at 30 June 2024, the Group has no capital commitments other than in relation to financial instruments (30 June 2023: £nil, 31 December 2023: £nil).

In addition, the Group has commitments relating to future acquisitions:

-    In February 2021, the Group announced the purchase of certain products in Phoenix's savings business offered through abrdn's Wrap platform, comprising a self-invested pension plan (SIPP) and an onshore bond product; together with Phoenix's trustee investment plan business for UK pension scheme clients. The transfers to the Group of the majority of the SIPP contracts and the TIP business are expected to be completed during 2025, subject to regulatory and court approvals. The upfront consideration paid by the Group in February 2021 was £62.5m, which is offset in part by payments from Phoenix to the Group relating to profits of the products prior to completion of the legal transfer. The net amount of consideration paid is included in prepayments in the condensed consolidated statement of financial position with cash movements in relation to the consideration included in prepayment in respect of potential acquisition of customer contracts in the condensed consolidated statement of cash flows. Refer Note 4.14 for details of the release of the prepayments to expenses in the six months ended 30 June 2024.

-    At 30 June 2024, the Group had other commitments for the cost of obtaining customer contracts for £22m. These commitments were subject to the satisfaction of certain conditions.

4.22 Related party transactions

In the normal course of business, the Group enters into transactions with related parties that relate to investment management and insurance businesses. There have been no changes in the nature of these transactions during the period to those reported in the Annual report and accounts for the year ended 31 December 2023. There were no transactions with related parties during the six months ended 30 June 2024 which had a material effect on the results or financial position of the Group.

4.23 Events after the reporting period

On 2 July 2024, the Group completed the sale of its adviser support services business, threesixty services, to the Fintel group. The threesixty services business was reported within our Adviser segment. The sale involved the transfer of 70 employees and resulted in an IFRS profit on disposal of subsidiaries and other operations of £9m which will be recognised in the second half of 2024.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Abrdn (ABDN)
UK 100

Latest directors dealings